Skip to main content
Sansure Biotech Inc. logo

Sansure Biotech Inc. — Investor Relations & Filings

Ticker · 688289 ISIN · CNE1000043J1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2022-07-13 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 688289

About Sansure Biotech Inc.

https://www.sansureglobal.com/

Sansure Biotech Inc. specializes in the development and manufacture of molecular diagnostic products and genetic testing solutions. The company utilizes proprietary technologies, such as the "One-tube" fast extraction method and advanced magnetic bead technology, to provide high-sensitivity PCR diagnostic kits. Its product portfolio covers a wide range of clinical applications, including infectious disease screening for hepatitis, respiratory infections, and sexually transmitted infections, as well as oncology and maternal health. Sansure also provides integrated laboratory automation systems, including nucleic acid extractors and real-time PCR instruments, designed to streamline clinical workflows and improve diagnostic efficiency for healthcare providers and research institutions globally.

Recent filings

Filing Released Lang Actions
圣湘生物科技股份有限公司关于股份回购实施结果的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from 圣湘生物科技股份有限公司 regarding the implementation results of a share repurchase program. It details the approval, execution, and completion of the share buyback, including the number of shares repurchased, prices, and the use of funds. It also discusses the handling of the repurchased shares and confirms no changes in control or impact on listing status. The document is not a full financial report but a specific update on share repurchase activity. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length is 1842 characters, which is consistent with an announcement rather than a full report.
2022-07-13 Chinese
圣湘生物科技股份有限公司2022年第一次临时股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as the "2022 First Extraordinary General Meeting (EGM) Meeting Materials" of 圣湘生物科技股份有限公司. It contains detailed meeting instructions, agenda, and multiple proposals for electing members of the board of directors and supervisory board. The content is focused on the materials provided for the shareholders to review and vote on during the EGM. There is no financial data, earnings information, or audit content. The document is not a report itself but the materials for a shareholders meeting. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during general meetings. Although it is an extraordinary meeting, the category AGM-R applies to all general meeting materials. The document length is over 5,000 characters and contains detailed meeting materials, not just an announcement or notice, so it is not RPA or RNS.
2022-07-07 Chinese
圣湘生物科技股份有限公司关于以集中竞价交易方式回购股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from 圣湘生物科技股份有限公司 regarding the progress of its share repurchase program conducted via centralized bidding transactions. It details the board's approval of the repurchase plan, the repurchase price limits, the cumulative shares repurchased, and compliance with regulatory guidelines. The document does not contain financial statements or detailed financial analysis but focuses on the update of the company's share buyback activity. This matches the description of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares.
2022-07-04 Chinese
圣湘生物科技股份有限公司独立董事关于第一届董事会2022年第五次临时会议相关事宜的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on the nomination of candidates for the company's second board of directors, including both non-independent and independent directors. It references compliance with company law, stock exchange listing rules, and company articles of association. The document is dated July 1, 2022, and is related to a board meeting. It does not contain financial statements or results but focuses on board nominations and governance matters. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2022-07-01 Chinese
圣湘生物科技股份有限公司关于董事会、监事会换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election and re-election of the company's board of directors and supervisory board members. It details the nomination process, candidate qualifications, and upcoming shareholder meeting to approve these changes. There is no financial data, earnings information, or audit content. The document focuses on management and board composition changes, which aligns with announcements about changes in the company's board or senior management. Therefore, the document fits the category of Board/Management Information (MANG). The document length is sufficient and contains detailed candidate biographies and election procedures, confirming it is not a brief announcement or a report publication notice.
2022-07-01 Chinese
圣湘生物科技股份有限公司第一届监事会2022年第四次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from the supervisory board (监事会) of 圣湘生物科技股份有限公司 regarding the nomination of candidates for the second supervisory board. It details the meeting date, attendance, resolutions passed, and voting results. It references compliance with company law and stock exchange rules. The content focuses on board/management changes, specifically nominations for supervisory board members, and mentions that the matter will be submitted to the shareholders' meeting. There is no financial data, earnings information, or report publication. The document is not a report itself but an announcement of board-related decisions. Therefore, it fits best under Board/Management Information (MANG).
2022-07-01 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.